Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Actin vs Try Ageless

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.0

Actin

Best for affordable compounded semaglutide with B12 enhancement
★★★3.5

Starting at $133/mo

Compounded SemaglutideB12 Enhanced
Visit Actin
6.8

Try Ageless

Best for Cost-sensitive patients seeking the lowest-tier compounded GLP-1 prices with a LegitScript-verifiable telehealth platform, especially those who want non-injectable oral forms (drops or troche) for needle-aversion and accept the weaker oral-compounded evidence base.
★★★☆☆3.4

Starting at $119/mo

Compounded Semaglutide — injection + troche + drops (sublingual)Compounded Tirzepatide — injection + drops (sublingual)LegitScript Certified (ID 123956 verifiable)Verbatim FDA compounded-medication disclaimer published
Visit Try Ageless

Side-by-Side Comparison

FeatureActinTry Ageless
Overall Score7.0/106.8/10
Starting Price$133/mo$119/mo
Editorial Rating3.5 ★ /53.4 ★ /5
Features2 features7 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Actin

Pros

  • Semaglutide + B12 combination for added energy support
  • Transparent pricing — exact cost shown upfront with no hidden fees
  • Competitive starting price from $133

Cons

  • Semaglutide only — no tirzepatide or liraglutide
  • No visible LegitScript or PCAB accreditation
  • State availability not disclosed
  • Broader platform (hormones, sexual wellness, hair health)

Try Ageless

Pros

  • LegitScript Certified with visible ID (123956) — verifiable signal vs badge-only competitors
  • THREE compounded form factors offered: injection, troche, sublingual drops — broadest DTC form-factor range in the WLR directory
  • Verbatim FDA compounded-medication disclaimer published (uncommon transparency)
  • Among the lowest advertised introductory prices — semaglutide injection $119/mo is one of the cheapest tier-1 prices we track
  • Delaware corporate address disclosed (Suite 305, 131 Continental Dr, Newark, DE 19713)
  • Longevity + metabolic health positioning aligns with the broader DTC longevity-medicine trend

Cons

  • Introductory pricing (-17% to -30% discounts) — refill/maintenance pricing not disclosed publicly; common DTC pattern is price escalation post-introductory tier
  • Pharmacy partner NOT named (only 'state-licensed pharmacies' generic framing)
  • States-served list NOT enumerated — 'Availability depends on your state' framing
  • Named medical director NOT disclosed
  • 503A vs 503B compounding designation NOT specified
  • Compounded oral forms (drops, troche) have weaker evidence base vs injectable — no STEP/SURMOUNT-equivalent oral compounded RCTs
  • Corporate legal entity (LLC/Inc/PC) NOT explicitly disclosed (Newark DE address suggests DE LLC, but designation absent)
  • Broad longevity-platform scope may dilute weight-loss-specific clinical focus vs specialist competitors

Our Verdict

Winner: ActinScore: 7.0/10

Actin edges out Try Ageless with a higher overall score of 7.0/10 and is particularly strong for affordable compounded semaglutide with B12 enhancement. Try Ageless remains a solid alternative, especially if you're looking for Cost-sensitive patients seeking the lowest-tier compounded GLP-1 prices with a LegitScript-verifiable telehealth platform, especially those who want non-injectable oral forms (drops or troche) for needle-aversion and accept the weaker oral-compounded evidence base..

Glossary references

Key terms in this article, linked to their canonical definitions.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.